Trial Profile
Oral anticoagulant therapy in USA patients with venous thromboembolism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 21 Nov 2016 New trial record